Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Integration of Electrochemical Sensing and Machine Learning to Detect Tuberculosis via Methyl Nicotinate in Patient Breath

Mary A. Jeppson, Zachary Rasmussen, Robert Castro, Talemwa Nalugwa, Esther Kisakye, Wilson Mangeni, Alfred Andama, Devan Jaganath, Adithya Cattamanchi, Swomitra K. Mohanty
doi: https://doi.org/10.1101/2024.05.23.24307746
Mary A. Jeppson
1Department of Chemical Engineering, The University of Utah, Salt Lake City, UT 84112 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zachary Rasmussen
1Department of Chemical Engineering, The University of Utah, Salt Lake City, UT 84112 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Castro
2Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA 94110 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Talemwa Nalugwa
3Walimu, Kampala Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther Kisakye
3Walimu, Kampala Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wilson Mangeni
3Walimu, Kampala Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfred Andama
4Walimu and the Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Devan Jaganath
5Division of Pediatric Infectious Diseases and the Center for Tuberculosis, University of California San Francisco, San Francisco, CA 94110 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adithya Cattamanchi
6Division of Pulmonary Diseases & Critical Care Medicine, University of California Irvine, Irvine, CA 92697 USA and the Center for Tuberculosis, University of California San Francisco, San Francisco, CA 94110 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Swomitra K. Mohanty
7Department of Chemical Engineering and the Department of Materials Science and Engineering, The University of Utah, Salt Lake City, UT 84112 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: swomitra{at}chemeng.utah.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Tuberculosis (TB) remains a significant global health issue; making early, accurate, and inexpensive point-of-care detection critical for effective treatment. This paper presents a clinical demonstration of an electrochemical sensor that detects methyl-nicotinate (MN), a volatile organic biomarker associated with active pulmonary tuberculosis. The sensor was initially tested on a patient cohort comprised of 57 adults in Kampala, Uganda, of whom 42 were microbiologically confirmed TB-positive and 15 TB-negative. The sensor employed a copper(II) liquid metal salt solution with a square wave voltammetry method tailored for MN detection using commercially available screen-printed electrodes. An exploratory machine learning analysis was performed using XGBOOST. Utilizing this approach, the sensor was 78% accurate with 71% sensitivity and 100% specificity. These initial results suggest the sensing methodology is effective in identifying TB from complex breath samples, providing a promising tool for non-invasive and rapid TB detection in clinical settings.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the National Institutes of Health, National Heart, Lung and Blood Institute, under Grant R01HL139717, and the National Institutes of Allergy and Infectious Diseases, under Grant U01AI152087.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Makerere University, College of Health Science School of Medicine, IRB Approval Granted University of California-San Francisco Human Research Protection Program Institutional Review Board IRB Approval Granted IRB # 20-32670

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • (E-mail: mary.jeppson{at}utah.edu; zachary.rasmussen{at}utah.edu), (Email: Robert.Castro{at}ucsf.edu), (Email: talemwan{at}yahoo.co.uk; estherkisakye64{at}gmail.com; mangeniwil{at}gmail.com), (Email: andama.alf{at}gmail.com), (Email: devan.jaganath{at}ucsf.edu), (E-mail: adithya.cattamanchi{at}uci.edu), > (E-mail: swomitra{at}chemeng.utah.edu)

  • This version of the manuscript as been updated to include acknowledgement of funding sources.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 14, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Integration of Electrochemical Sensing and Machine Learning to Detect Tuberculosis via Methyl Nicotinate in Patient Breath
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Integration of Electrochemical Sensing and Machine Learning to Detect Tuberculosis via Methyl Nicotinate in Patient Breath
Mary A. Jeppson, Zachary Rasmussen, Robert Castro, Talemwa Nalugwa, Esther Kisakye, Wilson Mangeni, Alfred Andama, Devan Jaganath, Adithya Cattamanchi, Swomitra K. Mohanty
medRxiv 2024.05.23.24307746; doi: https://doi.org/10.1101/2024.05.23.24307746
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Integration of Electrochemical Sensing and Machine Learning to Detect Tuberculosis via Methyl Nicotinate in Patient Breath
Mary A. Jeppson, Zachary Rasmussen, Robert Castro, Talemwa Nalugwa, Esther Kisakye, Wilson Mangeni, Alfred Andama, Devan Jaganath, Adithya Cattamanchi, Swomitra K. Mohanty
medRxiv 2024.05.23.24307746; doi: https://doi.org/10.1101/2024.05.23.24307746

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)